Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit Falls
08/11/2022 08:46
Nov 8 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* INDIA'S DR. LAL PATHLABS SEPT-QUARTER CONSOL NET PROFIT
717
MILLION RUPEES VERSUS 950 MILLION RUPEES
* DR. LAL PATHLABS SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS
5.34 BILLION RUPEES VERSUS 4.98 BILLION RUPEES
* DR. LAL PATHLABS SEPT-QUARTER CONSOL PROFIT VIEW 769.8
MILLION
RUPEES -- REFINITIV IBES DATA
Source text for Eikon: ID:nBSE9bk0sF
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise